Asia Pacific Sepsis Diagnostics Market Size & Outlook
Asia Pacific sepsis diagnostics market, 2018-2030 (US$M)
Related Markets
Asia Pacific sepsis diagnostics market highlights
- The Asia Pacific sepsis diagnostics market generated a revenue of USD 195.3 million in 2022.
- The market is expected to grow at a CAGR of 10.4% from 2023 to 2030.
- In terms of segment, blood culture media was the largest revenue generating product in 2022.
- Assay Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2023 to 2030.
Asia Pacific data book summary
| Market revenue in 2022 | USD 195.3 million |
| Market revenue in 2030 | USD 431.0 million |
| Growth rate | 10.4% (CAGR from 2022 to 2030) |
| Largest segment | Blood culture media |
| Fastest growing segment | Assay Kits & Reagents |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Blood Culture Media, Assay Kits & Reagents, Software |
| Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 19.5% of the global sepsis diagnostics market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 431.0 million by 2030.
Blood culture media was the largest segment with a revenue share of 39.02% in 2022. Horizon Databook has segmented the Asia Pacific sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.
The incidence of sepsis is rising in Asia Pacific, driven by a higher rate of infections, an aging population, the development of new diagnostic tests, a rise in healthcare expenditure in the region, and the increasing prevalence of chronic diseases.
Furthermore, constant developments in molecular diagnostics technology, such as the I ntroduction of point-of-care testing devices & next-generation sequencing technology, and integration of machine learning & artificial intelligence are contributing to the regional market growth.
Moreover, the presence of several key players in the region. such as Abbott Laboratories; and Roche Diagnostics are contributing to the market growth in the region.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sepsis Diagnostics Market Scope
Sepsis Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific sepsis diagnostics market size, by country, 2018-2030 (US$M)
Asia Pacific Sepsis Diagnostics Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
